The effectivity of platelet rich plasma on melasma: A systematic review and meta-analysis | [Journal of Pakistan Association of Dermatologists • 2022]

Author(s):

1. E Hidayat: Departement of Dermatovenereology, Faculty of Medicine, Diponegoro University/ Dr. Kariadi General Hospital Medical Center,Jl. Dr. Sutomo No.16, 50244, Semarang,Indonesia

2. A Budiastuti: Departement of Dermatovenereology, Faculty of Medicine, Diponegoro University/ Dr. Kariadi General Hospital Medical Center,Jl. Dr. Sutomo No.16, 50244, Semarang,Indonesia

3. DA Malik: Departement of Dermatovenereology, Faculty of Medicine, Diponegoro University/ Dr. Kariadi General Hospital Medical Center,Jl. Dr. Sutomo No.16, 50244, Semarang,Indonesia

4. RI Widayati: Departement of Dermatovenereology, Faculty of Medicine, Diponegoro University/ Dr. Kariadi General Hospital Medical Center,Jl. Dr. Sutomo No.16, 50244, Semarang,Indonesia

5. P Riyanto: Departement of Dermatovenereology, Faculty of Medicine, Diponegoro University/ Dr. Kariadi General Hospital Medical Center,Jl. Dr. Sutomo No.16, 50244, Semarang,Indonesia

6. Muslimin: Departement of Dermatovenereology, Faculty of Medicine, Diponegoro University/ Dr. Kariadi General Hospital Medical Center,Jl. Dr. Sutomo No.16, 50244, Semarang,Indonesia

7. Hardian: Departement of Physiology, Faculty of Medicine, Diponegoro University, Jl. Prof. Soedarto, Tembalang , Semarang, Indonesia

Abstract:

Background Melasma is an acquired hyperpigmentation in the form light brown to dark brown macules on areas exposed to Ultraviolet (UV). Melasma accounts for 50% of aesthetic cases in Asia. Therapy of melasma depends on the type of melasma, the effectiveness of previous therapies, and the patient's expectations. Difficult in the management of melasma are frequent recalcitrant, tendency of recurrence, risk of side effects, long treatment and patient compliance. The latest therapy that is being used is Platelet rich plasma (PRP) containing TGF-ß1 which significantly suppresses melanin synthesis, thereby lowering the mMASI score of melasma patients. Methods Searching the electronic database Medline Pubmed, Scopus, EBSCOhost, ProQuest, Cochrane library, ClinicalTrials.gov, found 5 articles included in the qualitative (n=154 subjects) and 4 articles (n=103 subjects) included in the meta-analysis. Results The mean difference in mMASI scores before treatment in the PRP injection treatment group and the control group was negative. This value indicates a decrease in the mMASI score after PRP injection. The control group also showed the same thing. The greatest decrease in mMASI scores in the study by Gamea, 2020 with PRP injection and topical tranexamic acid treatment was 8.5±2.76, the smallest in the study by Sirithanabadeekul, 2019 in the control group receiving normal saline injection, which was -1.42±0.93. The heterogeneity test results showed Q value = 24,564, df = 3; p<0.001, I2= 87.787. The I2 test outcome with p<0.001 showed that the data were homogeneous. The meta-analysis results present the Q statistic value was z= -5.373 (p=<0.001). This shows that overall offering PRP can significantly reduce the mMASI score. Conclusion The implemented meta-analysis and systematic results show those who were given PRP intradermal injection therapy there was a decrease in mMASI scores that had occurred before treatment. The decrease in mMASI scores in the group given platelet rich plasma was lower than the control group given tranexamic acid injection in melasma patients.

Page(s): 103-116

DOI: DOI not available

Published: Journal: Journal of Pakistan Association of Dermatologists, Volume: 32, Issue: 1, Year: 2022

Keywords:

Melasma , Melasma , Abstract , tranexamid acid , eolgtPlatelet rich plasma , mMASI

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views